Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models.

Autor: Wenthe, Jessica1,2 (AUTHOR) jessica.wenthe@igp.uu.se, Eriksson, Emma1,2 (AUTHOR), Hellström, Ann-Charlotte1 (AUTHOR), Moreno, Rafael3 (AUTHOR), Ullenhag, Gustav1,4 (AUTHOR), Alemany, Ramon3 (AUTHOR), Lövgren, Tanja1 (AUTHOR), Loskog, Angelica1,2 (AUTHOR)
Zdroj: Journal of Translational Medicine. 7/27/2023, Vol. 21 Issue 1, p1-17. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje